Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates from patients newly identified as nasal carriers

Journal of Clinical Microbiology

Volumn 50, Issue 10, 2012, Pages 3283-3286

  Weir, Susan K ^a,b   Fram, Julia ^a   Berg, Gretchen ^a   Kabbani, Dima ^b   Strymish, Judith ^a,c   Tang, Melody ^d   Fitzsimmons, Dianne ^d   Brecher, Stephen M ^b,d   Gupta, Kalpana ^a,b  

^a VA Boston HCS ^*  (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d VA Boston HCS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PANTON VALENTINE LEUKOCIDIN; PSEUDOMONIC ACID;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DISEASE ASSOCIATION; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MECA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; MUPA GENE; NONHUMAN; NOSE SMEAR; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL;

AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BOSTON; CARRIER STATE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXOTOXINS; FEMALE; HUMANS; LEUKOCIDINS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MUPIROCIN; NASAL MUCOSA; NUCLEAR PROTEINS; STAPHYLOCOCCAL INFECTIONS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84866454489     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01143-12     Document Type: Article

References (25)

1. Arbefeville SS, et al. 2011. Prevalence and genetic relatedness of methicillin-susceptible Staphylococcus aureus isolates detected by the Xpert MRSA nasal assay. J. Clin. Microbiol. 49:2996-2999.
2. Blanc DS, et al. 2011. High proportion of wrongly identified methicillin-resistant Staphylococcus aureus carriers by use of a rapid commercial PCR assay due to presence of staphylococcal cassette chromosome element lacking the mecA gene. J. Clin. Microbiol. 49:722-724.
3. British Society for Antimicrobial Chemotherapy. 2012. Methods for antimicrobial susceptibility testing. British Society for Antimicrobial Chemotherapy, Birmingham, United Kingdom.
4. Clinical Laboratory Standards Institute. 2012. Performance standards for antimicrobial disk susceptibility tests; approved standard, 11th ed, MO2-A11. Clinical Laboratory Standards Institute, Wayne, PA.
5. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. 2004. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin. Infect. Dis. 39:776-782. (Pubitemid 39244289)
6. Desjardins M, Guibord C, Lalonde B, Toye B, Ramotar K. 2006. Evaluation of the IDI-MRSA assay for detection of methicillin-resistant staphylococcus aureus from nasal and rectal specimens pooled in a selective broth. J. Clin. Microbiol. 44:1219-1223.
7. Harbarth S, et al. 2008. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 299:1149-1157. (Pubitemid 351398429)
8. Huang SS, et al. 2011. Methicillin-resistant Staphylococcus aureus infection and hospitalization in high-risk patients in the year following detection.2 PLoS One 6:e24340. doi:10.1371/journal.pone.0024340.
9. Jain R, et al. 2011. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N. Engl. J. Med. 364:1419-1430.
10. Kluytmans J, Harbarth S. 2011. Control of MRSA in intensive care units. BMJ 343:d5885. (Comment.)
11. Kreisel KM, et al. 2011. USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections? Diagn. Microbiol. Infect. Dis. 70:285-290.
12. LaPlante KL, Caffrey AR, Gupta K. 2010. Prevention of surgical-site infections. N. Engl. J. Med. 362:1540-1541. (Author reply, 362:1542-1543.)
13. Lee AS, et al. 2011. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin. Infect. Dis. 52:1422-1430.
14. Lee AS, et al. 2011. Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital. J. Hosp. Infect. 77:360-362.
15. Lim MS, Marshall CL, Spelman D. 2006. Carriage of multiple subtypes of methicillin-resistant Staphylococcus aureus by intensive care unit patients. Infect. Control Hosp. Epidemiol. 27:1063-1067. (Pubitemid 44670982)
16. Maslow JN, et al. 1995. Variation and persistence of methicillin- resistant Staphylococcus aureus strains among individual patients over extended periods of time. Eur. J. Clin. Microbiol. Infect. Dis. 14:282-290.
17. Scanvic A, et al. 2001. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin. Infect. Dis. 32:1393-1398. (Pubitemid 32424271)
18. Schmitz FJ, et al. 2000. Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 44:3229-3231.
19. Schmitz FJ, et al. 1998. The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J. Antimicrob. Chemother. 42:489-495.
20. Shurland SM, et al. 2012. USA300 methicillin-resistant S. aureus (USA300 MRSA) colonization and the risk of MRSA infection in residents of extended-care facilities. Epidemiol. Infect. 140:390-399.
21. Tacconelli E, et al. 2009. Rapid screening tests for methicillin- resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect. Dis. 9:546-554.
22. Thomas CM, Hothersall J, Willis CL, Simpson TJ. 2010. Resistance to and synthesis of the antibiotic mupirocin. Nat. Rev. Microbiol. 8:281-289.
23. Tracy LA, et al. 2011. Staphylococcus aureus infections in US veterans, Maryland, USA, 1999-2008. Emerg. Infect. Dis. 17:441-448.
24. Zhang K, McClure JA, Elsayed S, Louie T, Conly JM. 2008. Novel multiplex PCR assay for simultaneous identification of community-associated methicillin-resistant Staphylococcus aureus strains USA300 and USA400 and detection of mecA and Panton-Valentine leukocidin genes, with discrimination of Staphylococcus aureus from coagulase-negative staphylococci. J. Clin. Microbiol. 46:1118-1122. (Pubitemid 351380013)
25. Zhang K, et al. 2004. New quadriplex PCR assay for detection of methicillin and mupirocin resistance and simultaneous discrimination of Staphylococcus aureus from coagulase-negative staphylococci. J. Clin. Microbiol. 42:4947-4955. (Pubitemid 39506193)